Can aripiprazole (Abilify) cause mood swings?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Aripiprazole and Mood Swings

Yes, aripiprazole can cause mood swings as a side effect, particularly irritability, which is documented as a significant adverse effect in clinical studies and guidelines. 1

Mechanism and Evidence

Aripiprazole is an atypical antipsychotic with a unique mechanism as a partial dopamine agonist. While it's used to treat mood disorders, it can paradoxically cause mood-related side effects:

  • In pediatric studies, irritability was specifically noted as a significant side effect of aripiprazole treatment 2
  • Retrospective cohort studies have shown that aripiprazole can cause mood-related symptoms, with irritability being specifically documented 2
  • Aripiprazole has been associated with impulsive-compulsive behaviors that can manifest as mood instability 3

Risk Factors for Mood Swings with Aripiprazole

Several factors increase the likelihood of experiencing mood swings while taking aripiprazole:

  • Dosage: Higher doses (>15mg daily) are more likely to cause mood-related side effects
  • Age: Children and adolescents appear more susceptible to irritability as a side effect 2
  • Pre-existing conditions: Patients with bipolar disorder may be more sensitive to medication-induced mood fluctuations
  • Medication interactions: Combining with other psychotropics may increase risk

Clinical Presentation

Aripiprazole-induced mood swings typically present as:

  • Irritability and agitation
  • Emotional lability (rapid mood changes)
  • Increased impulsivity
  • Behavioral activation
  • In some cases, hypomanic or manic-like symptoms

These symptoms often emerge within the first 30 days of treatment initiation or dose increase and typically resolve within 30 days of discontinuation or dose reduction 3.

Management Algorithm

  1. For mild mood swings:

    • Consider dose reduction (e.g., from 10mg to 5mg daily)
    • Monitor closely for 1-2 weeks for improvement
  2. For moderate mood swings:

    • Reduce dose by 50%
    • If no improvement within 2 weeks, consider medication switch
  3. For severe mood swings or emergent mania/hypomania:

    • Discontinue aripiprazole
    • Consider alternative medication class
    • Consider short-term anxiolytic for symptom management

Alternative Medication Options

If aripiprazole causes problematic mood swings, consider these alternatives based on the original indication:

  • For bipolar disorder: Quetiapine (initial dose 25-50mg, max 800mg/day) or olanzapine (initial dose 5mg, max 20mg/day)
  • For adjunctive depression treatment: Quetiapine (50-300mg/day) or brexpiprazole (0.5-3mg/day)
  • For schizophrenia: Risperidone (1-6mg/day) or paliperidone (3-12mg/day)

Monitoring Recommendations

When starting aripiprazole or adjusting doses:

  • Assess mood state at baseline and at each follow-up
  • Schedule follow-up within 2 weeks of initiation or dose change
  • Monitor for emergence of impulsive behaviors (gambling, hypersexuality)
  • Educate patients and families about potential mood-related side effects
  • Document mood changes using standardized rating scales when possible

Important Caveats

  • Abrupt discontinuation of aripiprazole can itself cause mood instability; taper gradually when possible
  • Mood swings may be difficult to distinguish from underlying psychiatric condition symptoms
  • The risk of mood swings must be balanced against the benefits of treatment for the primary condition
  • Patients with a history of bipolar disorder are at higher risk for medication-induced mood instability

Aripiprazole remains an effective medication for many conditions, but clinicians should maintain vigilance for mood-related adverse effects and be prepared to adjust treatment accordingly.

References

Guideline

QTc Interval Management and Agitation in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Is Aripiprazole (Abilify) suitable for patients with emotional dysregulation?
What medication changes should be made for a patient taking fluoxetine (40mg) and aripiprazole (2.5mg) who is experiencing hypomania and had a previous adverse reaction to aripiprazole dose increase?
What is the next best step in managing a 19-year-old patient with a history of anorexia, depression, and manic episodes, currently on aripiprazole (Abilify) 10mg, who reports improvement in psychotic symptoms but persistent depressive symptoms and suicidal ideation?
What is the most appropriate medication for a 29-year-old female with bipolar disorder, manic episode, who is concerned about weight gain and potential pregnancy?
What is the next step in managing a 19-year-old patient with psychosis, anorexia (eating disorder), borderline personality disorder, and suicidal ideation (SI), who has shown improvement in hallucinations and delusions with 10mg Abilify (aripiprazole) but appears flat and tired?
What are the implications and management of a lack of right ureteral jet?
What are the treatment options for lower extremity edema?
What blood tests are used to check for menopause?
What is the recommended treatment for a dental infection?
Is vaginal estrogen safe for a former breast cancer patient with no uterus, who has been cancer-free for 21 years, to treat recurrent Urinary Tract Infections (UTIs)?
What is the approach to evaluating and managing seizures in pediatric and neonatal patients with genetic and metabolic disorders?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.